• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在法国 COVID-19 大流行期间,大肠杆菌感染中产生超广谱β-内酰胺酶的比例下降。

Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in France.

机构信息

Centre d'appui à la prévention des infections associées aux soins des Pays de la Loire. CHU - Le Tourville, 5 rue Pr Yves Boquien, Nantes 44093, France.

Département des Maladies Infectieuses, Santé Publique France, Saint Maurice, France.

出版信息

J Infect. 2021 Dec;83(6):664-670. doi: 10.1016/j.jinf.2021.09.016. Epub 2021 Sep 29.

DOI:10.1016/j.jinf.2021.09.016
PMID:34600019
Abstract

OBJECTIVES

We investigated the impact of the COVID-19 and national pandemic response on the epidemiology of Extended Spectrum Beta-Lactamase producing E. coli (ESBL-E.coli) in France.

METHODS

Individual microbiology records from clinical laboratories were analyzed between 1 January 2019 to 31 December 2020. The ESBL-E.coli rates from clinical samples of patients in primary care and nursing home residents were compared before and after the general lockdown in March 2020, according to demographic and geographical characteristics. Interrupted time series analyses were performed to detect measurable changes in the trend of ESBL-E.coli rates.

RESULTS

Records covering 793,954 E. coli isolates from 1022 clinical laboratories were analyzed. In primary care, 3.1% of E. coli isolates from clinical samples were producing ESBL before March 2020 and 2.9% since May 2020 (p < 0.001). The proportion of ESBL-E.coli decreased significantly among urine cultures, females, age categories 5-19, 40-64, > 65 year-old, and in the North, West, East and South-East regions. In nursing home, the ESBL-E.coli rate was 9.3% (monthly rate min-max: 6.5-10.5%) before March 2020 and 8.3% (7.2-9.1%) since May 2020 (p < 0.001). The reduction rate accelerated from -0.04%/month to -0.22%/month from May 2020 (p < 0.001).

CONCLUSION

Investigation of factors that led to the decreased proportion of ESBL-E.coli during the COVID-19 pandemic is urgently needed.

摘要

目的

我们研究了 COVID-19 大流行和国家大流行应对措施对法国产超广谱β-内酰胺酶大肠埃希菌(ESBL-E.coli)流行病学的影响。

方法

分析了 2019 年 1 月 1 日至 2020 年 12 月 31 日期间来自临床实验室的个体微生物学记录。根据人口统计学和地理位置特征,比较了 2020 年 3 月全面封锁前后初级保健和护理院居民临床样本中 ESBL-E.coli 的发生率。采用中断时间序列分析来检测 ESBL-E.coli 发生率趋势中的可衡量变化。

结果

分析了来自 1022 个临床实验室的 793954 株大肠埃希菌的记录。在初级保健中,2020 年 3 月之前,临床样本中 3.1%的大肠埃希菌产生 ESBL,而 2020 年 5 月以来为 2.9%(p<0.001)。尿液培养物、女性、5-19 岁、40-64 岁、>65 岁和北部、西部、东部和东南部地区的 ESBL-E.coli 比例显著下降。在护理院,2020 年 3 月之前,ESBL-E.coli 的发生率为 9.3%(每月发生率最小-最大:6.5-10.5%),而 2020 年 5 月以来为 8.3%(7.2-9.1%)(p<0.001)。自 2020 年 5 月以来,下降速度从每月 -0.04%加快至 -0.22%(p<0.001)。

结论

迫切需要调查导致 COVID-19 大流行期间 ESBL-E.coli 比例下降的因素。

相似文献

1
Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in France.在法国 COVID-19 大流行期间,大肠杆菌感染中产生超广谱β-内酰胺酶的比例下降。
J Infect. 2021 Dec;83(6):664-670. doi: 10.1016/j.jinf.2021.09.016. Epub 2021 Sep 29.
2
Impact of the COVID-19 pandemic on extended-spectrum β-lactamase producing Escherichia coli in urinary tract and blood stream infections: results from a nationwide surveillance network, Finland, 2018 to 2022.COVID-19 大流行对尿路感染和血流感染中产超广谱β-内酰胺酶大肠埃希菌的影响:来自全国监测网络的结果,芬兰,2018 年至 2022 年。
Antimicrob Resist Infect Control. 2024 Jul 6;13(1):72. doi: 10.1186/s13756-024-01427-z.
3
Trends in the Rates of Extended-Spectrum-β-Lactamase-Producing Isolated from Urine Cultures during the COVID-19 Pandemic in Ontario, Canada.加拿大安大略省 COVID-19 大流行期间尿液培养中产Extended-Spectrum-β-Lactamase 的分离株的流行率趋势。
Microbiol Spectr. 2023 Feb 14;11(1):e0312422. doi: 10.1128/spectrum.03124-22. Epub 2023 Jan 16.
4
Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in community-onset urinary tract infections in France in 2013.2013 年法国社区获得性尿路感染中产超广谱β-内酰胺酶大肠埃希菌的流行情况。
J Infect. 2016 Feb;72(2):201-6. doi: 10.1016/j.jinf.2015.11.009. Epub 2015 Dec 15.
5
Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.通过改变抗菌药物使用政策控制儿童医院中产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌
J Antimicrob Chemother. 2007 Sep;60(3):629-37. doi: 10.1093/jac/dkm225. Epub 2007 Jun 27.
6
Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings.大肠埃希菌和肺炎克雷伯菌中的超广谱β-内酰胺酶(ESBL):医院和社区环境中的趋势
J Infect Dev Ctries. 2009 May 1;3(4):295-9. doi: 10.3855/jidc.127.
7
Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.质粒介导产AmpCβ-内酰胺酶的大肠杆菌在奥克兰社区引起尿路感染,可能对常用抗菌药物耐药。
N Z Med J. 2015 Mar 13;128(1410):50-9.
8
Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.某地区医院急诊科临床分离肠杆菌科细菌的药敏情况:养老院居民中广谱β-内酰胺酶产生菌的威胁
J Microbiol Immunol Infect. 2016 Aug;49(4):584-90. doi: 10.1016/j.jmii.2015.10.001. Epub 2015 Nov 19.
9
Prevalence and patient related factors associated with Extended-Spectrum Beta-Lactamase producing Escherichia coli and Klebsiella pneumoniae carriage and infection among pediatric patients in Tanzania.坦桑尼亚儿科患者中产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌携带和感染的流行情况及与患者相关的因素。
Sci Rep. 2021 Nov 23;11(1):22759. doi: 10.1038/s41598-021-02186-2.
10
Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.5 年间加拿大医院分离的产超广谱β-内酰胺酶、AmpC 酶和碳青霉烯酶大肠埃希菌和肺炎克雷伯菌的分子流行病学研究:CANWARD 2007-11。
J Antimicrob Chemother. 2013 May;68 Suppl 1:i57-65. doi: 10.1093/jac/dkt027.

引用本文的文献

1
The challenge of multidrug resistance in hospitalized pediatric patients with urinary tract infections.住院小儿尿路感染患者多重耐药的挑战。
Front Cell Infect Microbiol. 2025 Jul 1;15:1570405. doi: 10.3389/fcimb.2025.1570405. eCollection 2025.
2
Associations between antibiotic consumption intensity and extended-spectrum cephalosporin resistance in nursing homes: a retrospective ecological study.养老院抗生素使用强度与超广谱头孢菌素耐药性之间的关联:一项回顾性生态学研究。
JAC Antimicrob Resist. 2025 May 23;7(3):dlaf088. doi: 10.1093/jacamr/dlaf088. eCollection 2025 Jun.
3
Rebound of Antibiotic Use and Respiratory Infections After Resumption of Normalcy From COVID-19 in Hong Kong.
香港从新冠疫情恢复正常后抗生素使用及呼吸道感染的反弹情况。
Infect Drug Resist. 2025 Mar 11;18:1325-1337. doi: 10.2147/IDR.S502126. eCollection 2025.
4
Detection of O25B-ST131 clone and gene in isolated from patients with COVID-19.从新冠肺炎患者中分离出的O25B-ST131克隆及基因的检测。
PeerJ. 2025 Mar 6;13:e19011. doi: 10.7717/peerj.19011. eCollection 2025.
5
Impact of the COVID-19 pandemic on extended-spectrum β-lactamase producing Escherichia coli in urinary tract and blood stream infections: results from a nationwide surveillance network, Finland, 2018 to 2022.COVID-19 大流行对尿路感染和血流感染中产超广谱β-内酰胺酶大肠埃希菌的影响:来自全国监测网络的结果,芬兰,2018 年至 2022 年。
Antimicrob Resist Infect Control. 2024 Jul 6;13(1):72. doi: 10.1186/s13756-024-01427-z.
6
Distribution and molecular characterization of carbapenemase-producing gram-negative bacteria in Henan, China.中国河南产碳青霉烯酶的革兰氏阴性菌的分布及分子特征。
Sci Rep. 2024 Jun 22;14(1):14418. doi: 10.1038/s41598-024-65106-0.
7
Wild-Type AmpC Beta-Lactamase-Producing Are a Risk Factor for Empirical Treatment Failure in Patients with Bloodstream Infection.产野生型AmpCβ-内酰胺酶是血流感染患者经验性治疗失败的一个危险因素。
Diseases. 2024 Mar 2;12(3):52. doi: 10.3390/diseases12030052.
8
Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance.2019冠状病毒病大流行后的抗菌药物耐药性
Antibiotics (Basel). 2024 Feb 29;13(3):233. doi: 10.3390/antibiotics13030233.
9
Decline in ESBL Production and Carbapenem Resistance in Urinary Tract Infections among Key Bacterial Species during the COVID-19 Pandemic.新冠疫情期间主要细菌种类引起的尿路感染中ESBL产生及碳青霉烯类耐药性的下降
Antibiotics (Basel). 2024 Feb 26;13(3):216. doi: 10.3390/antibiotics13030216.
10
Distribution and Drug Resistance of Bacterial Infection in Hospitalized Patients at the Respiratory Department before and after the COVID-19 Pandemic in Guangzhou, China.中国广州 COVID-19 大流行前后呼吸内科住院患者细菌感染的分布及耐药性
Microorganisms. 2023 Oct 12;11(10):2542. doi: 10.3390/microorganisms11102542.